Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N,N'-dimethyl-N-(acetyl)-N'-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)ethylenediamine, also known by code DB08751, is an experimental synthetic small molecule that functions as a fluorescent probe. It has been developed and investigated as an alternative to antibodies for use in fluorescent immunoassays, where its intrinsic fluorescent properties allow for diagnostic detection and imaging.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on n,n'-dimethyl-n-(acetyl)-n'-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)ethylenediamine.